SBC Medical Group (SBC) Stock Price, News & Analysis

Company Overview

SBC Medical Group, Inc. is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services. SBC Medical Group leverages proprietary software platforms and workflow automation tools to manage patient registration, claims submission and payment reconciliation. By integrating clinical documentation improvement and audit support, the company aims to reduce denials, accelerate cash collections and ensure adherence to regulatory requirements.

Operating across the United States, SBC Medical Group partners with a range of specialties including diagnostic imaging, physical therapy, laboratory services and radiation therapy providers. The company’s end-to-end service model is tailored to the specific needs of each client, enabling faster onboarding of new sites and scalability as practices expand. SBC Medical Group’s leadership team brings experience from healthcare operations, technology development and financial services to drive growth and operational excellence.

Key Stats

• Today's Range: $3.99 to $4.20
• 50-Day Range: $3.99 to $5.65
• 52-Week Range: $2.62 to $12.50
• Volume: 33,645 shs
• Average Volume: 40,272 shs
• Market Capitalization: $431.10 million
• P/E Ratio: 12.97
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SBC Stock Analysis - Frequently Asked Questions

How have SBC shares performed this year?

SBC Medical Group's stock was trading at $5.56 on January 1st, 2025. Since then, SBC stock has decreased by 25.4% and is now trading at $4.15.

How were SBC Medical Group's earnings last quarter?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) released its quarterly earnings results on Wednesday, August, 13th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.14 by $0.12. The company had revenue of $43.36 million for the quarter, compared to analyst estimates of $44.71 million. SBC Medical Group had a net margin of 17.71% and a trailing twelve-month return on equity of 20.76%.
Read the conference call transcript.

Who are SBC Medical Group's major shareholders?

Top institutional investors of SBC Medical Group include Geode Capital Management LLC (0.09%), SBI Securities Co. Ltd. (0.05%), New York State Common Retirement Fund (0.02%) and XTX Topco Ltd (0.01%).

How do I buy shares of SBC Medical Group?

Shares of SBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SBC Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SBC Medical Group investors own include Faraday Future Intelligent Electric (FFIE), Mastech Digital (MHH), Phoenix Motor (PEV), Top KingWin (TCJH), Agora (API) and American Outdoor Brands (AOUT).

Company Calendar

• Last Earnings: 8/13/2025
• Today: 9/06/2025
• Next Earnings (Estimated): 11/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:SBC
• Previous Symbol: NASDAQ:SBC
• CIK: 1930313
• Web: sbc-holdings.com
• Phone: 808-892-6611
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.32
• Trailing P/E Ratio: 12.97
• Forward P/E Ratio: 0.83
• P/E Growth: N/A
• Net Income: $46.61 million
• Net Margins: 17.71%
• Pretax Margin: 34.09%
• Return on Equity: 20.76%
• Return on Assets: 15.56%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 3.98
• Quick Ratio: 3.95

Sales & Book Value

• Annual Sales: $205.42 million
• Price / Sales: 2.10
• Cash Flow: $0.61 per share
• Price / Cash Flow: 6.84
• Book Value: $1.90 per share
• Price / Book: 2.18

Miscellaneous

• Outstanding Shares: 103,880,000
• Free Float: 10,939,000
• Market Cap: $431.10 million
• Optionable: N/A
• Beta: 1.27